All Pharma News
Why Is Liver-Disease Drug Developer Hepion Stock Trading Lower On Monday?

Why Is Liver-Disease Drug Developer Hepion Stock Trading Lower On Monday?
Vandana Singh YAHOO
23 Apr 2024
Share Share
Hepion Initiates Wind-Down Activities in Phase 2b ˜ASCEND-NASH™ Trial

Hepion Initiates Wind-Down Activities in Phase 2b ˜ASCEND-NASH™ Trial
GLOBENEWSWIRE
19 Apr 2024
Share Share
Hepion Strengthens Board of Directors with Appointment of Michael Purcell

Hepion Strengthens Board of Directors with Appointment of Michael Purcell
GLOBENEWSWIRE
06 Mar 2024
Share Share
Hepion Announces Exercise of Warrants for $2.0M Aggregate Gross Proceeds

Hepion Announces Exercise of Warrants for $2.0M Aggregate Gross Proceeds
GLOBENEWSWIRE
16 Feb 2024
Share Share
Hepion Pharmaceuticals to Present at NASH-TAG 2024

Hepion Pharmaceuticals to Present at NASH-TAG 2024
GLOBENEWSWIRE
03 Jan 2024
Share Share
Hepion Pharmaceuticals Announces Restructuring Plan

Hepion Pharmaceuticals Announces Restructuring Plan
GLOBENEWSWIRE
07 Dec 2023
Share Share
NASH drugmaker Hepion to seek strategic alternatives

NASH drugmaker Hepion to seek strategic alternatives
Kyle LaHucik ENDPTS
07 Dec 2023
Share Share
Hepion’s NASH trial hangs in balance amid cost-cutting, CEO exit

Hepion’s NASH trial hangs in balance amid cost-cutting, CEO exit
Gabrielle Masson FIERCE BIOTECH
07 Dec 2023
Share Share
Hepion Pharma to Present at the 7th Obesity & NASH Drug Development Summit

Hepion Pharma to Present at the 7th Obesity & NASH Drug Development Summit
GLOBENEWSWIRE
28 Nov 2023
Share Share
Hepion Announces Major Reductions in Liver Stiffness with Rencofilstat Treatment

Hepion Announces Major Reductions in Liver Stiffness with Rencofilstat Treatment
GLOBENEWSWIRE
13 Nov 2023
Share Share